Company intelligence / Profile preview

Xora Innovation

Ownership: Private
Development stage: Other

Overview

Xora Innovation does not have clinical results as it is an investment firm. Its portfolio includes early-stage biotech and deep tech ventures with a focus on disruptive scientific breakthroughs across healthcare, biotechnology, artificial intelligence, clean energy, and more. Portfolio examples include Allozymes (enzyme discovery), Think Bioscience (synthetic biology for small molecules), Nuevocor (gene therapy for cardiomyopathy).

Modalities: Small moleculeGene therapyEnzyme engineering
Industry: Investors

Partnerships

Academic institutions such as SMART/MIT Alliance for research commercialization projects

Beyond the preview

Go deeper on Xora Innovation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xora Innovation.

Explore the full profile